Company Overview

UFP Technologies, Inc. (NASDAQ: UFPT) is a U.S.-based designer and manufacturer of specialty engineered components, primarily serving the medical, defense, aerospace, industrial, and consumer markets. The company develops custom packaging, protective products, and engineered components using foams, films, plastics, and advanced material conversion technologies. Its operations are concentrated in highly regulated and specification-driven industries where product protection, sterilization compatibility, and precision manufacturing are critical.

The company’s primary revenue drivers are medical-device-related products and custom-engineered components used in minimally invasive surgery, orthopedic implants, infection prevention, wearable medical systems, and diagnostic applications. UFP Technologies has evolved from a regional foam-conversion business founded in 1963 into a diversified engineered materials company through acquisitions, internal manufacturing expansion, and increasing specialization in medical markets. Public filings and investor materials indicate that medical applications have become the company’s dominant strategic focus and largest end market.

Business Operations

UFP Technologies operates through a single reportable segment but manages a portfolio of specialized manufacturing operations and brands focused on engineered material solutions. The company designs and manufactures products using polyurethane foam, polyethylene foam, cross-linked foam, molded fiber, plastics, films, and other advanced materials. Core capabilities include thermoforming, laminating, molding, radio-frequency welding, die cutting, clean-room manufacturing, and packaging design. The company generates revenue primarily through long-term customer relationships involving customized product development and manufacturing for regulated industries.

Operations are primarily located in the United States, with additional manufacturing and operational presence in regions including Mexico, Ireland, and other international locations supporting medical-device customers and global supply chains. Major subsidiaries and acquired businesses include Molded Fiber Technology, Contech Medical, Das Medical, Advant Medical, and AQF Medical, which expanded the company’s medical manufacturing and sterile packaging capabilities. The company also maintains relationships with large medical-device OEMs and defense contractors through supply agreements and collaborative product-development arrangements.

Strategic Position & Investments

UFP Technologies has pursued a strategy centered on expanding its medical-device manufacturing platform, increasing exposure to higher-margin engineered products, and broadening clean-room and precision-conversion capabilities. The company has consistently invested in acquisitions that strengthen its position in medical packaging, single-use surgical systems, infection prevention products, and advanced wound-care applications. Acquisitions including Advant Medical and AQF Medical significantly expanded European manufacturing capabilities and increased the company’s participation in minimally invasive surgical and robotic-assisted procedure markets.

The company’s strategic positioning is supported by expertise in regulated manufacturing environments, customer-specific engineering, and vertically integrated production processes. UFP Technologies has also invested in facility expansion, automation, and clean-room infrastructure to support demand from medical-device customers. Public disclosures indicate continued emphasis on high-growth healthcare sectors, including robotic surgery, diagnostics, wearable medical technologies, and protective medical packaging. While defense and aerospace remain meaningful end markets, management communications and filings consistently identify medical technologies as the company’s primary long-term growth engine.

Geographic Footprint

UFP Technologies is headquartered in Newburyport, Massachusetts, and operates manufacturing and engineering facilities across multiple regions in North America and Europe. The company maintains a broad operational footprint through facilities in states including Massachusetts, Texas, California, Rhode Island, and other U.S. manufacturing hubs. Internationally, the company has expanded operations through acquisitions and customer-driven manufacturing support in Ireland, Mexico, and additional locations serving multinational medical-device companies.

The company’s customer base includes global manufacturers in healthcare, defense, aerospace, and industrial sectors. Its international operational presence is primarily tied to supporting multinational OEM supply chains and regional manufacturing requirements. Public filings and investor presentations indicate that international expansion has increasingly focused on medical-device production and sterile packaging capabilities in European markets, particularly following recent acquisitions.

Leadership & Governance

UFP Technologies is led by an executive team with backgrounds in engineered materials, medical manufacturing, operations management, and industrial product development. The company emphasizes operational discipline, customer-specific engineering, and acquisition-driven growth focused on specialized healthcare manufacturing capabilities. Governance oversight is provided through a board structure aligned with public-company standards and SEC reporting requirements.

Key executives include:

• R. Jeffrey Bailly – Chairman and Chief Executive Officer
• Ronald J. Lataille – Chief Financial Officer and Treasurer
• Daniel C. Croteau – President
• Patrick M. Kinney – Vice President, Corporate Development
• Christopher P. Litterio – Vice President, Operations

Company leadership has consistently communicated a strategic vision centered on expanding medical-market penetration, integrating acquisitions efficiently, and increasing value-added manufacturing capabilities through investment in technology, automation, and regulatory-compliant production infrastructure.